Drug Profile
Research programme: human papillomavirus DNA vaccine - Genvax
Latest Information Update: 07 May 2010
Price :
$50
*
At a glance
- Originator Genvax
- Class DNA vaccines; Papillomavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Human papillomavirus infections
Most Recent Events
- 10 Sep 2007 Preclinical trials in Human papillomavirus infections in United Kingdom (Parenteral)
- 30 Sep 2006 Early research in Human papillomavirus infections in United Kingdom (Parenteral)